Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 19, 2013
Patent Application Number
13372426
Date Filed
February 13, 2012
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
Provided are certain methods of screening, identifying, and evaluating neuroprotective compounds useful for treatment of neurological diseases, such as, e.g., multiple sclerosis (MS). The compounds described upregulate the cellular cytoprotective pathway regulated by Nrf2. Also provided are certain methods of utilizing such compounds in therapy for neurological disease, particularly, for slowing or reducing demyelination, axonal loss, or neuronal and oligodendrocyte death.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
